Chuan-Dong Cheng (Chuandong Cheng)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Long Noncoding Rna

Top Venues

Molecular medicine (Cambridge, Mass.)

Cell death discovery

Cancer gene therapy

Analytical cellular pathology (Amsterdam)

This page only lists publications with an associated author ORCID identifier.

Publications

Zixuan Wang, Xiaolong Qiao, Yinan Chen, Nan Peng, Chaoshi Niu, Yang Wang, Cong Li, Zengchun Hu, Caihua Zhang, Chuan-Dong Cheng
SVIP reduces IGFBP-2 expression and inhibits glioblastoma progression via stabilizing PTEN. Cell death discovery 10 (1) (2024)
Zixuan Wang, Xiaolong Qiao, Yinan Chen, Nan Peng, Chaoshi Niu, Yang Wang, Cong Li, Zengchun Hu, Caihua Zhang, Chuan-Dong Cheng
SVIP reduces IGFBP-2 expression and inhibits glioblastoma progression via stabilizing PTEN. Cell death discovery 10 (1) (2024)
Hongwei Zhang, Zixuan Wang, Xiaolong Qiao, Nan Peng, Jiaxing Wu, Yinan Chen, Chuan-Dong Cheng
Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Hongwei Zhang, Zixuan Wang, Xiaolong Qiao, Nan Peng, Jiaxing Wu, Yinan Chen, Chuan-Dong Cheng
Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Zixuan Wang, Xiaolong Qiao, Yinan Chen, Nan Peng, Chaoshi Niu, Yang Wang, Cong Li, Zengchun Hu, Caihua Zhang, Chuan-Dong Cheng
SVIP reduces IGFBP-2 expression and inhibits glioblastoma progression via stabilizing PTEN. Cell death discovery 10 (1) (2024)
Hongwei Zhang, Zixuan Wang, Xiaolong Qiao, Nan Peng, Jiaxing Wu, Yinan Chen, Chuan-Dong Cheng
Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Xiaolong Qiao, Yinan Chen, Zixuan Wang, Nan Peng, Wanxiang Niu, Shiqiang Hou, Jiaying Wu, Ying Ji, Chaoshi Niu, Chuan-Dong Cheng
GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma. Cancer gene therapy (2023)
Chuan-Dong Cheng, Cheng Chen, Li Wang, Yong-Fei Dong, Yang Yang, Yi-Nan Chen, Wan-Xiang Niu, Wen-Chao Wang, Qing-Song Liu, Chao-Shi Niu
Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations. Analytical cellular pathology (Amsterdam) 2022 (2022)